KALA - Kala pharmaceuticals appoints Francis Mah as Chief Medical Advisor
2023-03-29 09:31:17 ET
- Kala Pharma ( NASDAQ: KALA ) said it had appointed Francis Mah as the company's Chief Medical Advisor.
- The company said Mah would serve in the role on a part time basis and will continue his ongoing position as Director of Cornea and External Disease and the Co-Director, Refractive Surgery at Scripps Clinic.
- Mah will play a key role in interactions with eye care and professionals and help to advance the development of KPI-012 for persistent corneal epithelial defect (PCED) and other rare diseases.
- ( KALA ) rose 1.8% .
- Press Release
For further details see:
Kala pharmaceuticals appoints Francis Mah as Chief Medical Advisor